Faller, Eamonn and Jackson, A. (2022) A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic courses. Journal of Chemotherapy. ISSN 1120-009X
Text (A Cost Minimisation Analysis Comparing Oral Linezolid and Intravenous Daptomycin Administered via an Outpatient Parenteral Antibiotic Therapy Programme in Patients Requiring Prolonged Antibiotic Courses)
- Accepted Version
Download (624kB) |
Abstract
This study is an economic analysis seeking to examine cost savings that may be accrued from usage of oral linezolid in place of OPAT IV daptomycin in patients requiring prolonged courses of IV or highly bioavailable oral antibiotic therapy. In order to do so we conducted a literature review to establish the scenarios in which the agents could be considered equivalent. We then, using a decision-tree model, conducted a cost analysis to establish differences in cost between the approaches. Under the model base-case, the total cost of treatment with OPAT daptomycin was €3,496.84 and the total cost of treatment with oral linezolid was €772.01. Therefore the oral linezolid strategy would be projected to save the Irish health service €2,724.83 per patient. These results were robust to one-way deterministic sensitivity analyses and probabilistic sensitivity analysis. Our study suggests that significant savings could be safely accrued in the management of these patients.
Item Type: | Article |
---|---|
Additional Information: | © 2022 Edizioni Scientifi che per l’Informazione su Farmaci e Terapia. |
Divisions: | LSE |
Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine |
Date Deposited: | 06 Dec 2022 11:54 |
Last Modified: | 12 Dec 2024 03:27 |
URI: | http://eprints.lse.ac.uk/id/eprint/117535 |
Actions (login required)
View Item |